Featured Research

from universities, journals, and other organizations

A Novel Approach To Cancer Therapy

Date:
June 20, 2007
Source:
University Of Surrey
Summary:
Cancer sometimes involves processes that should only occur in the embryo being mistakenly reactivated in adult cells. Researchers have exploited this to develop a novel therapeutic strategy. This has led to the development of a new drug, HXR9 that blocks the activity of a group of genes known as the HOX family.

Cancer sometimes involves processes that should only occur in the embryo being mistakenly reactivated in adult cells. Researchers at the Postgraduate Medical School at the University of Surrey have exploited this to develop a novel therapeutic strategy. This has led to the development of a new drug, HXR9 that blocks the activity of a group of genes known as the HOX family.

Related Articles


The project leader, Dr Richard Morgan, explains ‘HOX genes are important in determining the identity of cells and tissues in the early embryo, but they are also expressed by cancer cells. HXR9 blocks HOX activity thereby killing cancer cells in a highly specific manner’. HXR9 shows particular promise in treating malignant melanoma together with lung, prostate and kidney cancer.

Work on HXR9 was started by Dr Morgan whilst he was a senior lecturer at St. George’s, University of London, and the University of Surrey has recently agreed a licensing deal to allow Dr Morgan to continue with the work at the PGMS.

Further work by the PGMS group has shown that embryonic genes expressed in cancer cells could also be important diagnostic markers. A number of embryonic proteins are secreted by prostate tumours and can be detected in blood serum, thereby providing a potential method for detecting prostate cancer and ultimately even assessing the extent of the disease without an invasive procedure. These findings have now been patented by the University of Surrey. The results appear in 'Cancer Research’ Journal.


Story Source:

The above story is based on materials provided by University Of Surrey. Note: Materials may be edited for content and length.


Cite This Page:

University Of Surrey. "A Novel Approach To Cancer Therapy." ScienceDaily. ScienceDaily, 20 June 2007. <www.sciencedaily.com/releases/2007/06/070619164739.htm>.
University Of Surrey. (2007, June 20). A Novel Approach To Cancer Therapy. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2007/06/070619164739.htm
University Of Surrey. "A Novel Approach To Cancer Therapy." ScienceDaily. www.sciencedaily.com/releases/2007/06/070619164739.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins